Clincosm LogoSign in Get a demo

stage iv renal cell cancer

Showing 26 - 50 of 61
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Cleveland (tandutinib,

Completed
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +2 more
  • Cleveland, Ohio
    Case Western Reserve University
Oct 19, 2017

Recurrent Renal Cell Carcinoma, Stage IV Renal Cell Cancer Trial in San Antonio (Vorinostat)

Completed
Has Results
  • Recurrent Renal Cell Carcinoma
  • Stage IV Renal Cell Cancer
  • San Antonio, Texas
  • +1 more
Oct 13, 2017

Adult Solid Tumor, Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Carcinoma Trial in Madison (Computed Tomography,

Completed
  • Adult Solid Neoplasm
  • +4 more
  • Computed Tomography
  • +5 more
  • Madison, Wisconsin
    University of Wisconsin Hospital and Clinics
Oct 9, 2017

Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Carcinoma, Recurrent Non-Small Cell Lung Carcinoma Trial in

Completed
  • Head and Neck Squamous Cell Carcinoma
  • +13 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Palo Alto, California
  • +4 more
Sep 14, 2017

Childhood Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma, Clear Cell Sarcoma of the Kidney Trial in Worldwide (drug,

Completed
Has Results
  • Childhood Renal Cell Carcinoma
  • +12 more
  • Doxorubicin Hydrochloride
  • +9 more
  • Birmingham, Alabama
  • +186 more
Jun 22, 2017

Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in United States (drug, other,

Terminated
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +2 more
  • pazopanib hydrochloride
  • +3 more
  • Chicago, Illinois
  • +3 more
May 8, 2017

Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Stanford (radiation, drug,

Terminated
  • Clear Cell Renal Cell Carcinoma
  • +2 more
  • stereotactic body radiation therapy
  • +3 more
  • Stanford, California
    Stanford University Hospitals and Clinics
Mar 13, 2017

Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Carcinoma, Stage IV Renal Cell Cancer Trial in Canada (Gamma-Secretase

Completed
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +2 more
  • Gamma-Secretase Inhibitor RO4929097
  • Laboratory Biomarker Analysis
  • Vancouver, British Columbia, Canada
  • +3 more
Jan 19, 2017

Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Carcinoma, Stage IV Renal Cell Cancer Trial in Houston (drug, biological,

Completed
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +2 more
  • Sorafenib Tosylate
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 28, 2016

Recurrent Renal Cell Carcinoma, Stage IV Renal Cell Cancer Trial in Canada (drug, procedure, other)

Completed
Has Results
  • Recurrent Renal Cell Carcinoma
  • Stage IV Renal Cell Cancer
  • Cediranib Maleate
  • +3 more
  • Edmonton, Alberta, Canada
  • +5 more
Jan 29, 2016

Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer Trial in Baltimore, Salisbury, Madison

Completed
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Baltimore, Maryland
  • +2 more
Dec 10, 2015

Adult Solid Tumor, Lung Carcinoid Tumor, Recurrent Digestive System Neuroendocrine Tumor G1 Trial in Vancouver, Hamilton,

Completed
  • Adult Solid Neoplasm
  • +10 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Vancouver, British Columbia, Canada
  • +2 more
Oct 5, 2015

Recurrent Renal Cell Carcinoma, Stage IV Renal Cell Cancer Trial in Tampa (Aldesleukin, Bevacizumab, Laboratory Biomarker

Completed
Has Results
  • Recurrent Renal Cell Carcinoma
  • Stage IV Renal Cell Cancer
  • Aldesleukin
  • +2 more
  • Tampa, Florida
    Moffitt Cancer Center
Jun 3, 2015

Recurrent Renal Cell Carcinoma, Stage IV Renal Cell Cancer Trial in Cleveland (Fluorouracil, Pharmacological Study, Suramin)

Completed
  • Recurrent Renal Cell Carcinoma
  • Stage IV Renal Cell Cancer
  • Cleveland, Ohio
    Cleveland Clinic Foundation
May 22, 2015

Chromophobe Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma Trial in Boston, Philadelphia,

Completed
Has Results
  • Chromophobe Renal Cell Carcinoma
  • +5 more
  • Bevacizumab
  • +3 more
  • Boston, Massachusetts
  • +4 more
Jan 6, 2015

Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Chicago (cediranib maleate,

Terminated
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +2 more
  • cediranib maleate
  • laboratory biomarker analysis
  • Chicago, Illinois
    University of Chicago
May 5, 2014

Recurrent Renal Cell Cancer, Renal Cell Carcinoma, Stage III Renal Cell Cancer Trial in United States (etaracizumab,

Terminated
Has Results
  • Recurrent Renal Cell Cancer
  • +3 more
  • Marysville, California
  • +4 more
Apr 28, 2014

Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage I Renal Cell Cancer Trial in Baltimore, Madison (drug,

Completed
  • Clear Cell Renal Cell Carcinoma
  • +6 more
  • sunitinib malate
  • +6 more
  • Baltimore, Maryland
  • +1 more
Apr 1, 2014

Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +84 more
  • sunitinib malate
  • +2 more
  • Los Angeles, California
  • +10 more
Mar 14, 2014

Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Duarte (recombinant interferon alfa, oblimersen sodium,

Completed
  • Recurrent Renal Cell Cancer
  • Stage IV Renal Cell Cancer
  • recombinant interferon alfa
  • +2 more
  • Duarte, California
    City of Hope
Aug 23, 2013

Stage IV Renal Cell Cancer, Recurrent Renal Cell Cancer Trial in United States (BAY 56-3722, enzyme inhibitor therapy)

Withdrawn
  • Stage IV Renal Cell Cancer
  • Recurrent Renal Cell Cancer
  • BAY 56-3722
  • enzyme inhibitor therapy
  • Little Rock, Arkansas
  • +25 more
Jul 9, 2013

Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Recurrent Renal Cell Cancer Trial in Durham (drug, biological,

Terminated
  • Clear Cell Renal Cell Carcinoma
  • +4 more
  • sorafenib tosylate
  • +2 more
  • Durham, North Carolina
    Duke University Medical Center
Jul 1, 2013

Stage IV Renal Cell Cancer, Recurrent Renal Cell Cancer Trial run by the NCI (bevacizumab, thalidomide)

Completed
  • Stage IV Renal Cell Cancer
  • Recurrent Renal Cell Cancer
  • Bethesda, Maryland
    Surgery Branch
Jun 19, 2013

Stage IV Melanoma, Stage IV Renal Cell Cancer, Recurrent Renal Cell Cancer Trial run by the NCI (flt3 ligand, gp100 antigen,

Completed
  • Stage IV Melanoma
  • +3 more
  • flt3 ligand
  • +4 more
  • Bethesda, Maryland
    Surgery Branch
Jun 19, 2013

Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Chicago (ispinesib)

Completed
  • Recurrent Renal Cell Cancer
  • +2 more
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
Jun 4, 2013